![]() |
市场调查报告书
商品编码
1848383
新型甜味剂市场预测至2032年:按产品类型、供应商、形态、分销管道、功能、应用和地区分類的全球分析Novel Sweeteners Market Forecasts to 2032 - Global Analysis By Product Type, Source, Form, Distribution Channel, Functionality, Application and By Geography |
||||||
根据 Stratistics MRC 预测,全球新型甜味剂市场预计到 2025 年将达到 37 亿美元,到 2032 年将达到 67 亿美元,预测期内复合年增长率为 8.5%。
新型甜味剂是利用先进的生物技术和合成过程开发的创新糖替代品。与传统甜味剂不同,它们通常具有更高的甜度、更低的热量和更佳的代谢特性。这些化合物,例如甜菊糖配糖体、罗汉果萃取物或阿洛酮糖,正越来越多地应用于食品和饮料配方中,以满足消费者对更健康、低糖食品的需求。儘管不同地区的监管核准和安全评估有所不同,但由于其功能多样性和在现代营养学中潜在的健康益处,新型甜味剂正获得越来越多的支持。
根据公共卫生营养学杂誌报道,2007 年至 2022 年间,包装食品和饮料中销售的非营养性甜味剂 (NNS) 的全球销售量将增长超过 36%,其中甜菊糖配糖体和蔗糖素在多个地区引领增长。
消费者对低热量、适合糖尿病患者食用的产品的需求日益增长
随着糖尿病和肥胖症发病率的上升,消费者正在积极寻找有助于血糖控制和体重管理的替代品。甜菊糖、罗汉果糖和阿洛酮糖等新型甜味剂因其天然来源且对血糖值影响较小而日益受到欢迎。食品和饮料生产商正在将这些甜味剂添加到零食、食品、饮料和烘焙产品中,以调整产品配方,以迎合注重健康的消费者的需求。此外,监管部门的核准和「清洁标籤」趋势也加速了这些甜味剂在主流市场和特色市场的普及。
新兴市场消费者意识较低
新兴市场的消费者往往因为熟悉且价格实惠而选择传统糖和人工甜味剂。然而,消费者对植物来源或发酵甜味剂的益处和安全性缺乏了解,阻碍了其市场渗透。此外,零售通路供应有限以及缺乏促销宣传活动也导致消费者认知度低落。製造商在建立信任和宣传新型甜味剂的功能优势方面面临许多挑战,尤其是在饮食习惯根深蒂固的都市区。
电子商务和健康意识零售通路的成长
数位化市场让消费者能够探索小众产品、比较成分并获得详细的营养资讯。品牌正利用电子商务进行精准行销宣传活动、提供订阅模式,并透过互动内容教育消费者。这种转变对希望直接触及消费者而无需依赖传统零售基础设施的中小型製造商尤其有利。
与传统人工甜味剂的竞争
由于成本低廉、供应链成熟且消费者认知度高,蔗糖素、阿斯巴甜和糖精等产品仍占主导地位。此外,糖在许多文化中仍然是主食,这使得消费者改变消费习惯变得困难。有些消费者觉得新的甜味剂口感不佳或不熟悉,从而减缓了其普及速度。价格敏感度和有限的扩充性进一步限制了市场成长,尤其是在那些消费者更重视性价比而非健康益处的地区。
新冠疫情的影响
疫情改变了消费者的关注重点,推动了对增强免疫力和健康产品(包括新型甜味剂)的兴趣。虽然疫情初期停工和供应链中断影响了生产和分销,但随着消费者在家庭烹饪和包装食品中寻求糖的替代品,需求逐渐恢復。对代谢健康和预防性营养的日益关注也促进了糖尿病友善甜味剂的销售。此外,数位健康意识的提高和远距医疗咨询的普及鼓励了人们改善饮食习惯,进一步推动了市场扩张。
预计在预测期内,罗汉果萃取物细分市场将成为最大的细分市场。
由于罗汉果萃取物不含卡路里且天然,预计其市场将迎来蓬勃发展。其源自罗汉果甜苷的浓郁甜味使其适用于多种应用,包括饮料、乳製品和糖果甜点。该萃取物的抗氧化特性以及美国和中国等主要市场良好的监管环境进一步提升了其市场吸引力。製造商正投资于可扩展的种植和提取技术,以满足不断增长的市场需求。
预计在预测期内,微生物发酵领域将实现最高的复合年增长率。
在生物技术和精准发酵技术的推动下,微生物发酵领域预计将在预测期内实现最快的复合年增长率。该方法能够以高纯度和最小的环境影响生产阿洛酮糖和塔格糖等稀有醣类。发酵甜味剂具有稳定的口感,并越来越多地应用于机能性食品和饮料行业。新兴企业和成熟公司都在探索利用发酵技术来克服植物来源甜味剂的供应限制。
由于农业产能强劲、健康意识不断增强以及政府积极采取措施,预计亚太地区将在预测期内占据最高的市场份额。中国、日本和韩国等国家正投资天然成分创新,并推行减糖政策。都市化和饮食偏好的改变正在推动对低热量产品的需求,尤其是在年轻一代。
预计在预测期内,北美将实现最高的复合年增长率,这主要得益于先进的食品加工技术和积极的法规环境。该地区的消费者越来越倾向于选择清洁标籤和生酮友善产品,这为新型甜味剂的推广创造了有利条件。领先的食品品牌正在调整产品配方以减少添加糖,而新兴企业则推出了甜味剂混合物和功能性糖浆等创新产品形式。美国食品药物管理局(FDA)核准多种新型甜味剂为「公认安全」(GRAS)物质,正在加速这些甜味剂的市场进入。
According to Stratistics MRC, the Global Novel Sweeteners Market is accounted for $3.7 billion in 2025 and is expected to reach $6.7 billion by 2032 growing at a CAGR of 8.5% during the forecast period. Novel sweeteners are innovative sugar alternatives developed through advanced biotechnological or synthetic processes. Unlike traditional sweeteners, they often offer enhanced sweetness intensity, minimal caloric impact, and improved metabolic profiles. These compounds such as steviol glycosides, monk fruit extracts, or allulose are increasingly used in food and beverage formulations to meet consumer demand for healthier, low-sugar options. Regulatory approval and safety assessments vary by region, but novel sweeteners are gaining traction for their functional versatility and potential health benefits in modern nutrition.
According Public Health Nutrition, the global volume of non-nutritive sweeteners (NNS) sold in packaged foods and beverages increased by over 36% between 2007 and 2022, with steviol glycosides and sucralose leading the growth across multiple regions.
Rising demand for low-calorie and diabetic-friendly products
As diabetes and obesity rates climb, consumers are actively seeking alternatives that support glycemic control and weight management. Novel sweeteners such as stevia, monk fruit, and allulose are gaining traction due to their natural origins and minimal impact on blood sugar levels. Food and beverage manufacturers are reformulating products to cater to health-conscious consumers, integrating these sweeteners into snacks, beverages, and bakery items. Additionally, regulatory approvals and clean-label trends are accelerating adoption across mainstream and specialty markets.
Limited consumer awareness in emerging markets
Consumers in these markets often rely on conventional sugar or artificial sweeteners due to familiarity and affordability. Educational gaps regarding the benefits and safety of plant-based or fermented sweeteners hinder market penetration. Moreover, limited availability in retail channels and lack of promotional campaigns restrict visibility. Manufacturers face challenges in building trust and communicating the functional advantages of novel sweeteners, especially in rural and semi-urban areas where dietary habits are deeply rooted.
Growth in e-commerce and health-focused retail channels
Digital marketplaces allow consumers to explore niche products, compare ingredients, and access detailed nutritional information. Brands are leveraging e-commerce to launch targeted marketing campaigns, offer subscription models, and educate buyers through interactive content. This shift is particularly beneficial for small and mid-sized manufacturers seeking direct-to-consumer engagement without relying on traditional retail infrastructure.
Competition from traditional and artificial sweeteners
Products like sucralose, aspartame, and saccharin continue to dominate due to their low cost, established supply chains, and widespread consumer recognition. Additionally, sugar remains a staple in many cultures, making behavioral shifts challenging. Some consumers perceive novel sweeteners as less palatable or unfamiliar, which can slow adoption. Price sensitivity and limited scalability further constrain market growth, especially in regions where cost-effective sweetening solutions are prioritized over health benefits.
Covid-19 Impact
The pandemic reshaped consumer priorities amplifying interest in immunity-boosting and health-conscious products including novel sweeteners. Lockdowns and supply chain disruptions initially affected production and distribution, but demand rebounded as consumers sought alternatives to sugar for home cooking and packaged foods. Increased focus on metabolic health and preventive nutrition drove purchases of diabetic-friendly sweeteners. Moreover, the rise of digital health awareness and remote wellness consultations encouraged dietary changes, supporting market expansion.
The monk fruit extract segment is expected to be the largest during the forecast period
The monk fruit extract segment is estimated to have a lucrative growth, due to its zero-calorie profile and natural origin. Its high-intensity sweetness, derived from mogrosides, makes it suitable for a wide range of applications including beverages, dairy, and confectionery. The extract's antioxidant properties and favorable regulatory status in key markets such as the U.S. and China further enhance its appeal. Manufacturers are investing in scalable cultivation and extraction technologies to meet rising demand.
The microbial fermentation segment is expected to have the highest CAGR during the forecast period
The microbial fermentation segment is anticipated to witness the fastest CAGR growth during the forecast period, driven by innovations in biotechnology and precision fermentation. This method enables the production of rare sugars like allulose and tagatose with minimal environmental impact and high purity. Fermentation-based sweeteners offer consistent taste profiles and are increasingly used in functional foods and beverages. Startups and established players alike are exploring fermentation to overcome supply limitations associated with plant-derived sweeteners.
Asia Pacific is projected to hold the highest market share during the forecast period owing to strong agricultural capabilities, rising health awareness, and favorable government initiatives. Countries like China, Japan, and South Korea are investing in natural ingredient innovation and promoting sugar reduction policies. Urbanization and changing dietary preferences are driving demand for low-calorie products, especially among younger demographics.
North America is projected to have the highest CAGR over the forecast period, fueled by advanced food processing technologies and a proactive regulatory environment. The region's consumers are increasingly adopting clean-label and keto-friendly products, creating fertile ground for novel sweeteners. Major food brands are reformulating offerings to reduce added sugars, while startups are introducing innovative formats such as sweetener blends and functional syrups. The U.S. FDA's recognition of several novel sweeteners as GRAS (Generally Recognized As Safe) is accelerating market entry.
Key players in the market
Some of the key players profiled in the Novel Sweeteners Market include Cargill Inc., Tate & Lyle PLC, Ingredion Incorporated, ADM (Archer Daniels Midland Company), Roquette Freres, GLG Life Tech Corporation, PureCircle, SweeGen Inc., Evolva Holding SA, Stevia First Corp, Matsutani Chemical Industry Co., Ltd., NutraSweet Natural, Xlear Inc., Zevia LLC, Whole Earth Brands, Biosweet Ventures, Health Garden USA, NOW Foods, Morita Kagaku Kogyo Co., Ltd., and Blue California.
In September 2025, Ingredion signed a conditional agreement to sell 51% of Rafhan Maize to Nishat Hotels. Ingredion will retain 20% ownership, pending international financing. The deal is expected to close in H1 2026.
In September 2025, Roquette completed its acquisition of IFF Pharma Solutions. H1 turnover grew 4% to €2.37B, with EBITDA up 18%. The company reorganized into two business groups for strategic focus.
In March 2025, NOW Foods launched Omega-3 Gummy Chews and Gaming Performance supplements. It expanded ISO 17025 testing and partnered with Brooks Beasts Track Club. The brand continues leading in clean-label innovation.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.